BioCentury | Apr 16, 2009
Distillery Therapeutics

Indication: Cancer

...therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Fyn-related kinase (FRK; RAK...
...at three weeks, whereas mice receiving RAK-expressing control cells did not. Cell-culture studies showed that RAK...
BioCentury | Dec 11, 2008
Targets & Mechanisms

Exosome brainstorm

...Rak authored the earlier exosome study that was also published in Nature Cell Biology. Rak...
...from OSI Pharmaceuticals Inc. , Genentech Inc. and Roche are reasonable treatment options, according to Rak...
...the indication. The drug is marketed for non-small cell lung cancer (NSCLC) and pancreatic cancer. Rak...
BioCentury | May 15, 2008
Cover Story

EGFR's New Tricks

...new vector for spreading cancer within the body, according to the study's lead author, Janusz Rak...
...but it has an impact on the entire tumor," Rak told SciBX . According to Rak...
...published online April 20, 2008; doi:10.1038/ncb1725 Contact: Janusz Rak, McGill University, Montreal, Quebec, Canada e-mail: janusz.rak@mcgill.ca...
BioCentury | May 8, 2008
Distillery Therapeutics

This Week in Therapeutics

...published online April 20, 2008; doi:10.1038/ncb1725 Contact: Janusz Rak, McGill University, Montreal, Quebec, Canada e-mail: janusz.rak@mcgill.ca BC...
Items per page:
1 - 4 of 4